Heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex

被引:1255
作者
Ohashi, K [1 ]
Burkart, V [1 ]
Flohé, S [1 ]
Kolb, H [1 ]
机构
[1] Univ Dusseldorf, German Diabet Res Inst, D-40225 Dusseldorf, Germany
关键词
D O I
10.4049/jimmunol.164.2.558
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human heat shock protein 60 (hsp60) elicits a potent proinflammatory response in cells of the innate immune system and therefore has been proposed as a danger signal of stressed or damaged cells, We report here that macrophages of C3H/HeJ mice, carrying a mutant Toll-like-receptor (Tlr) 4 are nonresponsive to hsp60. Both the induction of TNF-alpha and NO formation were found dependent on a functional Tlr4 whereas stimulation of macrophages by CpG DNA was Tlr4 independent. We conclude that Tlr4 mediates hsp60 signaling. This is the first report of a putative endogenous ligand of the Tlr4 complex.
引用
收藏
页码:558 / 561
页数:4
相关论文
共 31 条
[1]   Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2 [J].
Aliprantis, AO ;
Yang, RB ;
Mark, MR ;
Suggett, S ;
Devaux, B ;
Radolf, JD ;
Klimpel, GR ;
Godowski, P ;
Zychlinsky, A .
SCIENCE, 1999, 285 (5428) :736-739
[2]  
BURGESS AW, 1985, J BIOL CHEM, V260, P6004
[3]  
Chen W, 1999, J IMMUNOL, V162, P3212
[4]   Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction [J].
Chow, JC ;
Young, DW ;
Golenbock, DT ;
Christ, WJ ;
Gusovsky, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (16) :10689-10692
[5]  
FRIEDLAND JS, 1993, CLIN EXP IMMUNOL, V91, P58
[6]   CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation [J].
Häcker, H ;
Mischak, H ;
Miethke, T ;
Liptay, S ;
Schmid, R ;
Sparwasser, T ;
Heeg, K ;
Lipford, GB ;
Wagner, H .
EMBO JOURNAL, 1998, 17 (21) :6230-6240
[7]  
Heine H, 1999, J IMMUNOL, V162, P6971
[8]  
Hirschfeld M, 1999, J IMMUNOL, V163, P2382
[9]  
Hoshino K, 1999, J IMMUNOL, V162, P3749
[10]  
Jin FY, 1999, J IMMUNOL, V162, P3596